RxDoctor Payments DataLook up a doctor →

William Clark

Urology · Anchorage, AKNPI 1073567079

Payments from drug & device makers

$3,143,922in general payments, 2019–2025

Across 607 payments — averaging $5179.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$831K
  • Astellas Pharma Global Development$511K
  • Bayer$449K
  • Pfizer$418K
  • Medivation LLC.$290K
  • E.r. Squibb & Sons, L.L.C.$192K
  • plus $452K from 20 others
$1,255in research payments, 2019–2025

Across 12 payments — averaging $104.60 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • GSK$1K

General payments by program year

19
20
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,143,922 in reported general payments places this provider in the 95th percentile of 28 urology providers in Alaska.

See all urology providers in Alaska

Other urology in Anchorage

See the full list for Alaska

Where these figures come from

Is this you, or does something look wrong? →